MedTwenty Indices API Newsletters Sign in

MedTwentyUK Healthcare Business Intelligence

Create free account

Research Dashboards Membership

News · Category

Pharma & Biotech

Drug developers, biotech and life sciences.

All NHS & Policy Private Healthcare Healthcare Business Digital Health MedTech & Devices Pharma & Biotech Diagnostics Healthcare AI Hospitals Finance & M&A Venture Capital & Private Equity Workforce & Careers Global Markets Precision Medicine

All regions UK US Global

Trending this weekCancer Genomics 5 MHRA Approvals 5 Private Equity 5 Workforce 4 NHS Elective Recovery 3 Ambient AI 2

Nothing here yet

No published stories match these filters. Try another category or region.

Editors’ picks

1
Abridge raises $340m Series D to scale ambient AI across US health systems
Digital Health · 4 min read
2
Merck secures first approval for an oral PCSK9 inhibitor, reshaping the cholesterol market
Pharma & Biotech · 5 min read
3
FDA extends Casgevy approval to children aged two and over, raising payer coverage questions
MedTech & Devices · 4 min read

Deal flow tracker

Live · UK & Global20 deals this quarter

Tempus → Personalis

Diagnostics · Announced

$1.5bn

Spark Capital → Abridge

Digital Health · Closed

$340m

Optum → Landmark

Providers · Closed

$3.2bn

Spire Healthcare → [redacted]

Providers · Rumoured

Premium

Open full tracker

The MedTwenty Brief

The definitive Monday read on UK healthcare business: deals, decisions and what they mean.

MedTwenty

UK Healthcare Business Intelligence

300 stories screened. The twenty that matter.

The MedTwenty Brief

Intelligence

Companies
Executives
Investors
Technologies
Diseases
Markets
Deals
Indices

Editorial

News
Research
Newsletters
Editorial standards
Masthead

Company

About
Careers
Contact
API

Legal

Privacy
Terms
Cookies
Accessibility

MedTwenty Indices and trackers are editorial indicators and business information. They are not investment, financial, legal or medical advice, and not a regulated benchmark.

MedTwenty is a trading name of Vanadium Media Group Ltd, registered in England and Wales.

Contact: hello@medtwenty.com

© 2026 MedTwenty. All rights reserved.